# Safety and Immunogenicity of an A (H1N1) 2009 Influenza Virus-like Particle (VLP) Vaccine

> **NCT01072799** · PHASE2 · COMPLETED · sponsor: **Novavax** · enrollment: 4560 (actual)

## Conditions studied

- Seasonal Influenza

## Interventions

- **BIOLOGICAL:** Placebo
- **BIOLOGICAL:** A/H1N1 2009 Influenza VLP Vaccine

## Key facts

- **NCT ID:** NCT01072799
- **Lead sponsor:** Novavax
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 4560 (ACTUAL)
- **Last updated:** 2012-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01072799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01072799, "Safety and Immunogenicity of an A (H1N1) 2009 Influenza Virus-like Particle (VLP) Vaccine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01072799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*